Genome-wide Association for HF: From Discovery to Clinical Use Genome-wide Association for HF: From Discovery to Clinical Use

A new GWAS study has identified a a polygenic risk score that contributes to dilated cardiomyopathy, opening the door to clinical use of these scores for determining HF or DCM progression.European Heart Journal
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news